SahaD., AgarwalS.K.Hepatitis and HIV infection during haemodialysis.J Indian Med Assoc2001; 99: 194–9, 203, 213.
2.
AgarwalS.K., DashS.C., IrshadM.Hepatitis C virus infection during haemodialysis in India.J Assoc Physicians India1999; 47: 1139–43.
3.
DonahueJ.G., MunozA., NessP.M., BrownD.E.Jr., YawnD.H., McAllisterH.A.Jr.. The declining risk of post-transfusion hepatitis C virus infection.N Engl J Med1992; 327: 369–73.
4.
Le PogamS., Le ChapoisD., ChristenR., DuboisF., BarinF., GoudeauA.Hepatitis C in a hemodialysis unit: Molecular evidence for nosocomial transmission.J Clin Microbiol1998; 36: 3040–3.
5.
PujolF.H., PonceJ.G., LemaM.G., CaprilesF., DevesaM., SiritF.High incidence of HCV infection in units with high prevalence.J Clin Microbiol1996; 34: 1633–6.
6.
European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association.Haemodialysis-associated infection. Guideline VI.6.4.Nephrol Dial Transplant2002; 17(Suppl 7): 79.
7.
ChanT.M., LokA.S., ChengI.K.Hepatitis C infection among dialysis patients: A comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.Nephrol Dial Transplant1991; 6: 944–7.
8.
AkpolatT; Turkish Multicentre CAPD Study Group (TULIP). CAPD: A control strategy to prevent spread of HCV infection in end-stage renal disease.Perit Dial Int2001; 21: 77–9.
